ask="N/A"
ask_size="N/A"
average_daily_volume="37614"
bid="N/A"
bid_size="N/A"
book_value="0.452"
change="-0.058"
change_from_200_day_moving_average="-0.198"
change_from_50_day_moving_average="-0.600"
change_from_52_week_high="-2.048"
change_From_52_week_low="1.472"
change_in_percent="-1.758%"
close="3.242"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.443"
ebitda="-14.69M"
eps_estimate_current_year="-1.900"
eps_estimate_next_quarter="-0.130"
eps_estimate_next_year="-0.420"
ex_dividend_date="N/A"
float_shares="4912000"
high="3.300"
high_52_weeks="5.290"
last_trade_date="1/3/2017"
last_trade_price="3.242"
last_trade_size="100"
last_trade_time="4:02pm"
low="3.226"
low_52_weeks="1.770"
market_capitalization="49.06M"
moving_average_200_day="3.440"
moving_average_50_day="3.842"
name="NovaBay Pharmaceuticals
Inc. C"
notes="N/A"
one_year_target_price="7.500"
open="3.250"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-5.754%"
percent_change_from_50_day_moving_average="-15.613%"
percent_change_from_52_week_high="-38.715%"
percent_change_from_52_week_low="+83.164%"
previous_close="3.300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.301"
price_per_sales="5.282"
revenue="9.45M"
shares_outstanding="15134000"
short_ratio="10.270"
stock_exchange="ASE"
symbol="NBY"
volume="22914"
weeks_range_52="1.770 - 5.290"
